COVID-19 Update: We are currently shipping orders daily. However, due to transit disruptions in some geographies, deliveries may be delayed. To provide all customers with timely access to content, we are offering 50% off Science and Technology Print & eBook bundle options. Terms & conditions.
Drug Discovery Approaches for the Treatment of Neurodegenerative Disorders - 1st Edition - ISBN: 9780128028100, 9780128028117

Drug Discovery Approaches for the Treatment of Neurodegenerative Disorders

1st Edition

Alzheimer's Disease

Editor: Adeboye Adejare
Hardcover ISBN: 9780128028100
eBook ISBN: 9780128028117
Imprint: Academic Press
Published Date: 30th September 2016
Page Count: 316
Sales tax will be calculated at check-out Price includes VAT/GST
Price includes VAT/GST

Institutional Subscription

Secure Checkout

Personal information is secured with SSL technology.

Free Shipping

Free global shipping
No minimum order.


Drug Discovery Approaches for the Treatment of Neurodegenerative Disorders: Alzheimer’s Disease examines the drug discovery process for neurodegenerative diseases by focusing specifically on Alzheimer’s Disease and illustrating the paradigm necessary to ensure future research and treatment success.

The book explores diagnosis, epidemiology, drug discovery strategies, current therapeutics, and much more to provide a holistic approach to the discovery, development, and treatment of Alzheimer’s Disease. Through its coverage of the latest research in targeted drug design, preclinical studies, and mouse and rat models, the book is a must-have resource for all pharmaceutical scientists, pharmacologists, neuroscientists, and clinical researchers working in this area. It illustrates why these drugs tend to fail at the clinical stage, and examines Alzheimer’s Disease within the overall context of improving the drug discovery process for the treatment of other neurodegenerative disorders.

Key Features

  • Provides a compilation of chemical considerations required in drug discovery for the treatment of neurodegenerative disorders
  • Examines different classes of compounds currently being used in discovery and development stages
  • Explores in vitro and in vivo models with respect to their ability to translate these models to human conditions
  • Distills the most significant information across multiple areas of Alzheimer’s disease research to provide a single, comprehensive, and balanced resource


Professionals involved in the drug discovery process, whether in academia, research institutes or the pharmaceutical industry. This includes scientists who are involved in drug design to those involved in clinical trials

Table of Contents

  1. General description of neurodegenerative disorders
  2. Alzheimer’s disease diagnosis
  3. National plan and resources to address Alzheimer’s disease
  4. Current Medications for Treatment of Alzheimer's Disease:  Acetylcholine esterase inhibitors and NMDA receptor antagonist
  5. Physicochemical properties for potential AD drugs
  6. Receptor approaches
  7. Amyloid hypothesis
  8. Tau proteins
  9. Cholesterol and fat metabolism
  10. Energy Metabolism
  11. Simple in vivo models of Neurodegeneration (C. Elegans, fruitfly, and similar models)
  12. Rodent Models
  13. Clinical Trials
  14. Non-pharmacologic Treatment Approaches


No. of pages:
© Academic Press 2017
30th September 2016
Academic Press
Hardcover ISBN:
eBook ISBN:

About the Editor

Adeboye Adejare

Adeboye Adejare

Adeboye Adejare’s research group is interested in the areas of design and syntheses of small organic molecules to probe neurodegeneration, especially Alzheimer’s disease, and for treatment of cancer. They are also interested in in vitro models of drug absorption and ability to cross blood brain barrier; drug targeting; pharmaceutical profiling; and chemistry of fluoroaromatic compounds. The research is funded by the National Institutes of Health, the Office of Naval Research, and several pharmaceutical companies. These efforts have resulted in over 50 publications, 5 patents, and over 100 presentations at meetings, including invited presentations at national and international conferences. He also serves on several national panels, including those by NIH, NSF, and Alzheimer’s Association. Dr. Adejare is the editor of Drug Discovery Approaches for the Treatment of Neurodegenerative Disorders: Alzheimer’s Disease which is also published by Elsevier.

Affiliations and Expertise

Professor, Pharmaceutical Sciences, Philadelphia College of Pharmacy, University of the Sciences, Philadelphia, PA, USA

Ratings and Reviews